Susquehanna raised the firm’s price target on Caesars (CZR) to $34 from $32 and keeps a Positive rating on the shares. The firm updated its model following solid Q1 results. In particular, the favorable results/ near-term outlook arrive at an ideal time assuming a Fertitta bid is working its way through the due diligence process and would likely make a potential acquirer feel more welcome with a bid.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CZR:
